530207 — Brawn Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹55.51m
- IN₹41.13m
- IN₹164.95m
- 10
- 42
- 37
- 16
Annual cashflow statement for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Net Income/Starting Line | -4.12 | -15.4 |
| Depreciation | ||
| Non-Cash Items | -0.348 | 0.066 |
| Other Non-Cash Items | ||
| Changes in Working Capital | 6.55 | 14.6 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Accounts Payable | ||
| Change in Taxes Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | 3.18 | -0.256 |
| Capital Expenditures | -0.956 | -0.121 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | -0.956 | -0.121 |
| Financing Cash Flow Items | -0.082 | -0.038 |
| Other Financing Cash Flow | ||
| Cash from Financing Activities | -0.082 | -0.038 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 2.14 | -0.415 |